Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

Université de Montréal

$27,000.00

CGRS (Master's Program) Application - Gene expression profiles in ICU pharmacotherapy

FY 2025-26

Summary
Sedative and analgesic medications (SAM) are routinely used in the ICU for mechanical ventilation, but difficult to dose optimally, as critically ill patients exhibit marked variability in drug response. Suboptimal dosing can lead to serious adverse effects, notably iatrogenic withdrawal, prolonged ventilation, extended ICU stay, and delirium. Genetic variation and differential gene expression influence medication response, and have informed individualized therapy in other medical fields, but little evidence exists in critical care. We hypothesize that specific gene-expression patterns correlate with recovery from mechanical ventilation and can be used to predict ventilation duration. We plan to conduct a prospective cohort study of adults requiring >48 hours of mechanical ventilation for acute neurologic conditions. Whole blood will be collected longitudinally, gene expression profiled using Oxford Nanopore sequencing and quantified with lr-kallisto and Salmon. Dimensionality reduction will assess batch effects. Associations between temporal gene-expression trajectories and ventilator-free days at day 28 will be evaluated using a natural-splines interaction model incorporating key confounders, with multiple-testing correction applied. Genes most strongly associated with recovery from mechanical ventilation will be used to train parsimonious machine-learning models, validated by nested cross-validation, to predict ventilation duration. This study aims to identify clinically actionable transcriptomic markers and create a framework for integrating real-time molecular profiling into ICU decision-making to advance individualized pharmacotherapy.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
572615
Name
Li Qi
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
CGRS (Master's Program) Application - Gene expression profiles in ICU pharmacotherapy
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Genomic; Intensive Care; Mechanical Ventilation; Precision Medicine; Sedative And Analgesic Medications; Single Cell Nucleotide Sequencing; Transcriptomic
Abstract
Sedative and analgesic medications (SAM) are routinely used in the ICU for mechanical ventilation, but difficult to dose optimally, as critically ill patients exhibit marked variability in drug response. Suboptimal dosing can lead to serious adverse effects, notably iatrogenic withdrawal, prolonged ventilation, extended ICU stay, and delirium. Genetic variation and differential gene expression influence medication response, and have informed individualized therapy in other medical fields, but little evidence exists in critical care. We hypothesize that specific gene-expression patterns correlate with recovery from mechanical ventilation and can be used to predict ventilation duration. We plan to conduct a prospective cohort study of adults requiring >48 hours of mechanical ventilation for acute neurologic conditions. Whole blood will be collected longitudinally, gene expression profiled using Oxford Nanopore sequencing and quantified with lr-kallisto and Salmon. Dimensionality reduction will assess batch effects. Associations between temporal gene-expression trajectories and ventilator-free days at day 28 will be evaluated using a natural-splines interaction model incorporating key confounders, with multiple-testing correction applied. Genes most strongly associated with recovery from mechanical ventilation will be used to train parsimonious machine-learning models, validated by nested cross-validation, to predict ventilation duration. This study aims to identify clinically actionable transcriptomic markers and create a framework for integrating real-time molecular profiling into ICU decision-making to advance individualized pharmacotherapy.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Li, Qi
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~